Latest Articles

Whether you are a new lab starting up or a seasoned lab looking to upgrade your old equipment; there are many important aspects you need to think about before deciding to make your equipment purchase.

In this article, we chat to James Mcllory, CEO of EnteroBiotix, a Scottish biotech working to modulate the human microbiome to address unmet clinical needs.

Bills keep coming up and, so far, getting shot down.

To better understand the key challenges and pain points in the global laboratory market, Agilent commissioned Frost & Sullivan to carry out an independent survey of 700 scientists across the laboratory employee spectrum. Here we highlight a selection of the survey’s key findings.

U.S. government examples of cannabis, used in research, fail to replicate the cannabis that's available on the market.

Ken Keene Jr is making a video diary of his father Kenneth Keene Sr as he lives with Frontotemporal dementia.

With very few biomarkers having made it into clinical practice, we find out how some proteomics laboratories are using a factory-type set up to get more biomarkers into the clinic, faster.

Cannabis testing requirements keep changing in this state, and more adjustments probably lie ahead.

New diagnostic tool could therefore lead to improved therapeutic success and a better quality of life for the millions of patients suffering from Sjögren’s syndrome around the world.

The complexities of tumor genomes are rapidly being uncovered, but how they are regulated into functional proteomes remains poorly understood, until now.